Dutch extend reactor shut-down through November; docs to postpone exams

  
Petten reactor produces the majority of the world supply of isotopes of technetium. Image Source: Energieonderzoek Centrum Nederland (ECN) 
The High Flux Reactor (HRF) facility in Petten, the Netherlands, a major supplier of medical radioisotopes, has extended its halted production through November.

Earlier this month, the Nuclear Research and Consultancy Group, which operates the recently shuttered nuclear reactor, said it would not restart the reactor before the end of October. However, now that timeline has been extended.

The plant found that some pipes were corroded, and it is drawing up repair plans, spokeswoman Leontien Zuurbier told the International Herald Tribune. She also said that production at the plant would not resume before Nov. 23.

The Petten reactor produces around one-third of the global supply of radioisotopes, while the reactor in Canada provides half.

The European Association of Nuclear Medicine has advised hospitals to postpone non-urgent examinations and use substitutes for the isotope when possible. The association said that EU health officials have launched "coordinated action to ensure adequate supply."

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.